Dr. Anurodh Agrawal was born in India and completed his Masterís program from Tezpur University in Molecular Biology and Biotechnology. He got his first research exposure during his masters and worked on the project related to cloning, characterization and expression of hyper thermophilic bacterium Bacillus subtilis. To further explore his research potentialin microbiology, he joined the Ph.D. program from Jadavpur University in Virology where he was given the responsibility to set up the laboratory and the procedures. His work helped in rapid screening of many respiratory viruses from clinical samples and adaptation of these viruses in cell culture for basic study. He went for multiple training and workshops in the Referral laboratory at National Institute of Virology, Pune to gain expertise. He was able to process clinical samples by real-time PCR viral propagation methods. Due to hisinterest in molecular biology and epidemiology, he started collecting viral strains from hospitals for the surveillance on Influenza and other respiratory viruses and also started sequencing to for genetic and antigenic characterization.Hesuccessfully introduced multiplex real-time PCR system to screen many respiratory viruses, simultaneously. During his course of Ph.D., his findings were presented at many national or International conferences. He studied Host-Virus Interaction and Signaling mechanism in Influenza virus and also tested the prophylactic and therapeutic efficacy of the different natural antiviral compound. To further improve his scientific knowledge, he changed his area of research from Molecular Virology to Immunology and joined Duke University, the USAas a postdoc to study on antibody diversification and the major repair pathways which are involved during class switch recombination with emphasis to homologous recombination repair protein Xrcc3. After spending 2 years in Immunology lab, he moved to a research lab in UTMB, Galveston for his second Postdoc to work on translational research on the Middle East respiratory Syndrome (MERS) and generated the transgenic mice model and tested drugs for its therapeutic efficacy.
Pathogenesis of emerging RNA viruses; Innate antiviral signaling pathways against viral infections; Genomic Diversity and Evolution (Phylogenetic) of Viruses; Molecular Epidemiology; Antivirals and vaccine strategies against RNA viruses and drug development; Study of different repair pathways.